Apeiron Ria LLC Amgen Inc Transaction History

Apeiron Ria LLC

$343 Million
Q3 2024

A detailed history of Apeiron Ria LLC transactions in Amgen Inc stock. As of the latest transaction made, Apeiron Ria LLC holds 2,251 shares of AMGN stock, worth $652,564. This represents 0.21% of its overall portfolio holdings.

Number of Shares

2,251

Previous 2,208 1.95%

Holding current value

$652,564

Previous $689,000 5.22%

% of portfolio

0.21%

Previous 0.21%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $13,303 - $14,507	43 Added 1.95%	2,251 $725,000
Q2 2024 Jul 16, 2024	BUY	$262.75 - $319.31 $38,624 - $46,938	147 Added 7.13%	2,208 $689,000
Q1 2024 Apr 15, 2024	BUY	$268.87 - $324.56 $6,184 - $7,464	23 Added 1.13%	2,061 $585,000
Q4 2023 Jan 12, 2024	SELL	$255.7 - $288.46 $21,223 - $23,942	-83 Reduced 3.91%	2,038 $586,000
Q3 2023 Oct 19, 2023	BUY	$218.65 - $271.46 $15,961 - $19,816	73 Added 3.56%	2,121 $570,000
Q2 2023 Jul 20, 2023	BUY	$214.27 - $253.37 $44,139 - $52,194	206 Added 11.18%	2,048 $454,000
Q1 2023 Apr 13, 2023	BUY	$225.79 - $275.2 $9,483 - $11,558	42 Added 2.33%	1,842 $445,000
Q4 2022 Jan 20, 2023	BUY	$229.03 - $291.01 $3,206 - $4,074	14 Added 0.78%	1,800 $0
Q3 2022 Oct 18, 2022	BUY	$224.46 - $253.15 $400,885 - $452,125	1,786 New	1,786 $438,000
Q2 2022 Jul 26, 2022	SELL	$230.71 - $256.74 $242,014 - $269,320	-1,049 Closed	0 $0
Q1 2022 Apr 19, 2022	BUY	$219.27 - $242.57 $2,850 - $3,153	13 Added 1.25%	1,049 $264,000
Q4 2021 Feb 15, 2022	BUY	$198.88 - $227.6 $206,039 - $235,793	1,036 New	1,036 $233,000

Others Institutions Holding AMGN

# of Institutions

3,121

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $155B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Apeiron Ria LLC, based on Form 13F filings with the SEC.

News

Stay updated on Apeiron Ria LLC with notifications on news.

Account